{"altmetric_id":4555984,"counts":{"readers":{"mendeley":17,"citeulike":0,"connotea":0},"total":{"posts_count":1},"twitter":{"unique_users_count":1,"unique_users":["CancerPapers"],"posts_count":1}},"selected_quotes":["Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast\u2026 #breastcancer"],"citation":{"abstract":"Upon analysis of archived primary tumors of 482 patients with triple negative breast cancer (TNBC) enrolled in two randomized Phase III adjuvant chemotherapy trials, we have found that tumor infiltrating lymphocytes (TILs), as assessed and quantified by hematoxylin and eosin (H&E) staining are a robust and independent predictor of disease-free survival (DFS), distant recurrence-free interval (DRFI) and overall survival (OS).(1) Our findings provide confirmation of results observed in TNBC in a European adjuvant chemotherapy dataset and therefore elevate TILs as prognostic biomarker for operable TNBC to level I evidence.","altmetric_jid":"557ed87946ff25d2316639ec","authors":["Adams, Sylvia","Goldstein, Lori J","Sparano, Joseph A","Demaria, Sandra","Badve, Sunil S"],"doi":"10.4161\/2162402x.2014.985930","first_seen_on":"2015-09-26T10:13:25+00:00","funders":["niehs","nci"],"issns":["2162-4011","2162-402X"],"issue":"9","journal":"OncoImmunology","last_mentioned_on":1443262385,"links":["http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/26405612?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter"],"pmid":"26405612","pubdate":"2015-09-01T00:00:00+00:00","startpage":"e985930","title":"Tumor infiltrating lymphocytes (TILs) improve prognosis in patients with triple negative breast cancer (TNBC).","type":"article","volume":"4","mendeley_url":"http:\/\/www.mendeley.com\/research\/tumor-infiltrating-lymphocytes-tils-improve-prognosis-patients-triple-negative-breast-cancer-tnbc-1"},"altmetric_score":{"score":0.25,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":0.25},"context_for_score":null},"demographics":{"poster_types":{"member_of_the_public":1},"users":{"twitter":{"cohorts":{"Members of the public":1}},"mendeley":{"by_status":{"Student  > Doctoral Student":2,"Researcher":4,"Student  > Ph. D. Student":3,"Student  > Postgraduate":2,"Other":1,"Student  > Master":2,"Student  > Bachelor":3},"by_discipline":{"Medicine and Dentistry":7,"Immunology and Microbiology":1,"Agricultural and Biological Sciences":1,"Computer Science":1,"Biochemistry, Genetics and Molecular Biology":6,"Unspecified":1}}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/CancerPapers\/statuses\/647715506619682818","license":"gnip","citation_ids":[4555984],"posted_on":"2015-09-26T10:13:05+00:00","author":{"name":"Cancer Papers","image":"https:\/\/pbs.twimg.com\/profile_images\/610454165983244288\/dcwghekI_normal.jpg","description":"Stay abreast of the latest developments in the fight against cancer with daily publications curated from PubMed.","id_on_source":"CancerPapers","tweeter_id":"3326766226","geo":{"lt":null,"ln":null},"followers":722},"tweet_id":"647715506619682818"}]}}